| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2994 |
| Trial ID | NCT05333302 |
| Disease | Lymphoblastic Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Tocilizumab |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma |
| Year | 2022 |
| Country | Belarus |
| Company sponsor | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology |
| Other ID(s) | CD19CAR-T_LL_children |
| Cohort 1 | |||||||||||||
|
|||||||||||||